LL-37 is a cationic α-helical research peptide derived from the C-terminal region of human cathelicidin (hCAP18). It exhibits broad-spectrum antimicrobial and immunomodulatory activity in preclinical studies, acting via membrane disruption and modulation of TLR/NF-κB pathways. LL-37 is widely used in microbiology and immunology research investigating host defense peptides and innate immune signaling.
LL37 5 mg – 10 Vials
$110.00
Kit of 10 Vials – For Research Use Only – Not Intended for Human Consumption
Extra Features
- Premium Quality
- Secure Payments
- Satisfaction Guarantee
- Worldwide Shipping
- Money Back Guarantee
Be the first to review “LL37 5 mg – 10 Vials”
Reviews
There are no reviews yet.